Magic mushrooms 'reduce depression in cancer patients'
Single dose of psilocybin can boost mental wellbeing for up to six months, according to two clinical trials

A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
The psychedelic trip produced by magic mushrooms can lift anxiety and depression in people dealing with life-threatening cancer, according to two clinical trials in the US.
Researchers from Johns Hopkins University in Baltimore and NYU Langone Medical Centre in New York carried out trials on a total of 80 volunteers with cancer who had reported symptoms of depression and anxiety.
Participants were given either a high dose of psilocybin, the active ingredient in magic mushrooms, o or a placebo. They then took part in a psychotherapy session during which they were encouraged to focus on their inner experiences while researchers monitored them. A few weeks later, the patients had a second session with the other drug.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
In the Johns Hopkins study, 83 per cent of participants reported "decreases in measures of depression, anxiety and mood disturbance, and increases in measures of quality of life, life meaning, death acceptance and optimism", New Scientist reports.
The effect appears to be long lasting. "Six months after the final session of treatment, about 80 per cent of participants continued to show clinically significant decreases in depressed mood and anxiety," Medical Xpress reports.
The Guardian reports that the effects of magic mushrooms have been of interest to psychiatry since the 1950s, but the hardening of the US government's attitude towards recreational drug use after the late 1960s created "daunting legal and financial obstacles to running trials" with psychedelics.
A further practical difficulty in assessing hallucinogenics objectively is that participants in clinical trials are not supposed to know if they have received the real drug or a placebo, but the side effects of psychedelic drugs mean patients can tell if they have taken them.
Stephen Ross, the lead investigator on the NYU Langone trial, believes psilocybin's impact on patients' wellbeing far outstrips current treatment options, although he recognises the need for more research.
Between 40 and 50 per cent of cancer patients will develop depression or anxiety, but the current treatment options, such as antidepressants, "really don't work any better than placebo", he said.
If larger trials produce the same results, Ross says "psilocybin potentially could be rescheduled to become a prescription medication for cancer-related anxiety and depression".
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
-
6 vibrant homes with art studios
Feature Featuring a six-bedroom home in Vermont and a rustic-modern house in California
By The Week Staff Published
-
Experts are worried about tuberculosis again
Speed Read The deadly disease regained its crown as the world's biggest infectious killer in October 2022
By Devika Rao Published
-
The daily gossip: Beyoncé is bringing the 'Renaissance' tour to movie theaters, Taylor Swift attends another Chiefs game with famous pals, and more
Feature The daily gossip: October 2, 2023
By Brendan Morrow Published
-
Reader favourites
Speed Read A selection of short but sweet features from across The Week magazine
By The Week Staff Last updated
-
Home Office worker accused of spiking mistress’s drink with abortion drug
Speed Read Darren Burke had failed to convince his girlfriend to terminate pregnancy
By The Week Staff Published
-
In hock to Moscow: exploring Germany’s woeful energy policy
Speed Read Don’t expect Berlin to wean itself off Russian gas any time soon
By The Week Staff Published
-
Were Covid restrictions dropped too soon?
Speed Read ‘Living with Covid’ is already proving problematic – just look at the travel chaos this week
By The Week Staff Last updated
-
Inclusive Britain: a new strategy for tackling racism in the UK
Speed Read Government has revealed action plan setting out 74 steps that ministers will take
By The Week Staff Published
-
Sandy Hook families vs. Remington: a small victory over the gunmakers
Speed Read Last week the families settled a lawsuit for $73m against the manufacturer
By The Week Staff Published
-
Farmers vs. walkers: the battle over ‘Britain’s green and pleasant land’
Speed Read Updated Countryside Code tells farmers: ‘be nice, say hello, share the space’
By The Week Staff Published
-
Motherhood: why are we putting it off?
Speed Read Stats show around 50% of women in England and Wales now don’t have children by 30
By The Week Staff Published